Obestatin Promotes Survival of Pancreatic β-Cells and Human Islets and Induces Expression of Genes Involved in the Regulation of β-Cell Mass and Function

作者: R. Granata , F. Settanni , D. Gallo , L. Trovato , L. Biancone

DOI: 10.2337/DB07-1104

关键词:

摘要: OBJECTIVE— Obestatin is a newly discovered peptide encoded by the ghrelin gene whose biological functions are poorly understood. We investigated obestatin effect on survival of β-cells and human pancreatic islets underlying signaling pathways. RESEARCH DESIGN AND METHODS— β-Cells were used to assess cell proliferation, survival, apoptosis, intracellular signaling, expression. RESULTS— showed specific binding HIT-T15 INS-1E β-cells, bound glucagon-like peptide-1 receptor (GLP-1R), recognized sites. exerted proliferative, antiapoptotic effects under serum-deprived conditions interferon-γ/tumor necrosis factor-α/interleukin-1β treatment, particularly at pharmacological concentrations. Ghrelin antagonist [D-Lys 3 ]-growth hormone releasing peptide-6 anti-ghrelin antibody prevented obestatin-induced in islets. islet cells released obestatin, addition anti-obestatin reduced their viability. increased β-cell cAMP activated extracellular signal–related kinase 1/2 (ERK1/2) phosphatidylinositol 3-kinase (PI 3-kinase)/Akt; its was blocked inhibition adenylyl cyclase/cAMP/protein A (PKA), PI 3-kinase/Akt, ERK1/2 signaling. Moreover, upregulated GLP-1R mRNA insulin substrate-2 (IRS-2) expression phosphorylation. The exendin-(9-39) survival. In islets, immunoreactivity colocalized with that ghrelin, promoted cytokine-induced apoptosis through increase involvement cyclase/cAMP/PKA 1 ) induced ERK1/2, also response element–binding protein phosphorylation; 2 stimulated secretion expression; GLP-1R, IRS-2, duodenal homeobox-1, glucokinase mRNA. CONCLUSIONS— These results indicate promotes stimulates main regulatory genes, identifying new role for this within endocrine pancreas.

参考文章(50)
Máire E. Doyle, Josephine M. Egan, Mechanisms of action of glucagon-like peptide 1 in the pancreas Pharmacology & Therapeutics. ,vol. 113, pp. 546- 593 ,(2007) , 10.1016/J.PHARMTHERA.2006.11.007
A K Bassil, Y Häglund, J Brown, T Rudholm, P M Hellström, E Näslund, K Lee, G J Sanger, Little or no ability of obestatin to interact with ghrelin or modify motility in the rat gastrointestinal tract British Journal of Pharmacology. ,vol. 150, pp. 58- 64 ,(2007) , 10.1038/SJ.BJP.0706969
R Göke, Hans-Christoph Fehmann, T Linn, Harald Schmidt, Michael Krause, J Eng, B Göke, None, Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells. Journal of Biological Chemistry. ,vol. 268, pp. 19650- 19655 ,(1993) , 10.1016/S0021-9258(19)36565-2
S MOHANTY, G SPINAS, K MAEDLER, R ZUELLIG, R LEHMANN, M DONATH, T TRUB, M NIESSEN, Overexpression of IRS2 in isolated pancreatic islets causes proliferation and protects human beta-cells from hyperglycemia-induced apoptosis. Experimental Cell Research. ,vol. 303, pp. 68- 78 ,(2005) , 10.1016/J.YEXCR.2004.09.011
Valeria P. Carlini, Helgi B. Schiöth, Susana R. deBarioglio, Obestatin improves memory performance and causes anxiolytic effects in rats. Biochemical and Biophysical Research Communications. ,vol. 352, pp. 907- 912 ,(2007) , 10.1016/J.BBRC.2006.11.112
Giampiero Muccioli, Alessandra Baragli, Riccarda Granata, Mauro Papotti, Ezio Ghigo, Heterogeneity of ghrelin/growth hormone secretagogue receptors. Toward the understanding of the molecular identity of novel ghrelin/GHS receptors. Neuroendocrinology. ,vol. 86, pp. 147- 164 ,(2007) , 10.1159/000105141
T. Mandrup-Poulsen, beta-cell apoptosis: stimuli and signaling. Diabetes. ,vol. 50, ,(2001) , 10.2337/DIABETES.50.2007.S58
Haiying Cheng, Susanne G. Straub, Geoffrey W. G. Sharp, Inhibitory role of Src family tyrosine kinases on Ca2+-dependent insulin release. American Journal of Physiology-endocrinology and Metabolism. ,vol. 292, ,(2007) , 10.1152/AJPENDO.00103.2006
M. J. Iglesias, A. Salgado, R. Piñeiro, B. K. Rodiño, M. F. Otero, L. Grigorian, R. Gallego, C. Diéguez, O. Gualillo, J. R. González-Juanatey, F. Lago, Lack of effect of the ghrelin gene-derived peptide obestatin on cardiomyocyte viability and metabolism. Journal of Endocrinological Investigation. ,vol. 30, pp. 470- 476 ,(2007) , 10.1007/BF03346330
Saleem S. Qader, Rolf Håkanson, Jens F. Rehfeld, Ingmar Lundquist, Albert Salehi, Proghrelin-derived peptides influence the secretion of insulin, glucagon, pancreatic polypeptide and somatostatin: A study on isolated islets from mouse and rat pancreas. Regulatory Peptides. ,vol. 146, pp. 230- 237 ,(2008) , 10.1016/J.REGPEP.2007.09.017